Latest News | May 13, 2019

The Week in Review in Prescription Drug Pricing

This week the world welcomed a royal baby! However, unless your name is Archie Harrison Mountbatten-Windsor, you’ll probably still have to worry about the high cost of prescription drugs.

Welcome to the week in review in prescription drug pricing!

1. “It’ll be a big fight”

2. Sky high in July

3. Reference this

4. Patently absurd

5. Robber barons would blush

 
We would be remiss if we did not note the passing of one of the deans of health journalism, The New York Times’ Robert Pear. We will miss his kind spirit, tenacious reporting, and brilliant mind.
 
Robert, Thank You.

We hope you all have a chance to see Endgame this weekend. Our Endgame? Lower drug prices.

Welcome to the week in review in prescription drug pricing!
 
1. Fake patient advocacy on the rise

2. Woman v. The Machine

3. The Everglades

4. Good luck with that

5. America, meet the drug pricing vernacular

###

Welcome to the week in drug pricing news — no redactions.
 

1. Big Pharma: “We are going to put prices on our websites*”

2. The Big Pharma tax windfall goes to…


3. Main-ahs look into wicked high prices


4. Constituent: “Hi, I’m not calling about the Mueller report.”


5.  Let’s make a deal.

We finally know what a black hole looks like. Next black hole to face the cameras: justification for drug company price hikes.
 
1. Patients win

2. Counts for nothing

 
3. Do you like apples?


4. What a week in Washington

 
5. Walmart-ism

We won’t spoil Game of Thrones, but we will spoil Big Pharma’s ongoing attempt to rob us all.  
 
Welcome to the Week in Review in Prescription Drug Pricing!
 
1. Drowning in debt

 
2. Pharma on the run

 
3. Call us

 
4. Influence peddling in the commonwealth

 
5. Another week, another insulin pricing Band-Aid

If Alanis Morissette released her iconic album today, would it be called Jagged Little Overpriced Pill?
 
Welcome to the Week in Review in Prescription Drug Pricing.

1. Fear the Turtle

 
2. Taxpayers pay twice

 
3. Highway Robbery

 
4. Sticker shock won’t lower drug prices

 
5. Does not compute 

Will PhRMA partner with Lori Loughlin in an attempt to improve its reputation?
 
1. Bonuses for bad behavior


2. She sold everything — twice

 
3. Isn’t sepsis frightening enough? 

 
4. Everyone gets a piece of the pie

 
5. We’re not gonna take it

The bargain that wasn’t. A fight with BIO. And who will replace the commish?
 
Welcome to the week in review in prescription drug pricing!

1. No deal


2. Patients take center stage


3. The gloves are off


4. Big shoes to fill


5. Maryland leads the way